• תמונה1
  • תמונה 2
  • תמונה 3
  • תמונה 4
  • תמונה 5
  • תמונה 6

One Place for all your research needs

The Bar-Ilan Institute for Nanotechnology and Advanced Materials (BINA) is a leading global hub for research, innovation, and collaboration in nanotechnology and advanced materials, offering cutting-edge facilities through the BINA Center for Scientific Equipment. The BINA Center operates two main service divisions: Fabrication and Characterization, in addition to the Project & Industrial Relations Unit and Administration. Operating in full compliance with the ISO 9001 standard, BINA
upholds the highest standards of quality and excellence.

Find out what's going on
Bar Ilan's Institute of Nanotechnology and Advanced Materials (BINA)
PolyX Whats New?
We’re proud to be part of this winning consortium and to take an active role in the…
FIB Scientific Instrument
Nano-imaging, elemental composition analysis & high presicion milling,…
Biomedicine Research Fields
Biomedicine, the intersection of biology and medicine, is pivotal in advancing…
Prof. Doron Gerber Academic Staff

Viruses use very complex interaction networks to interface and hijack host machinery in order to do their bidding. Mapping protein interaction topologies represents a fundamental step towards understanding these biological processes. Over the last 3 years, I have developed quantitative high-throughput microfluidic tools and applied them to study protein interaction networks. These tools allow us to shed light on difficult biological questions with clinical implications. In many aspects, these questions could not be readily addressed with conventional methods (membrane protein expression, etc.). Viruses modulate host networks on the genometranscriptome and proteome levels. I would like to discover such viral-host interfaces by mapping viral protein interaction networks with the host genome, transcriptome and proteome. My research is guided by several questions: (1) What are the common "tools" viruses use to hijack host network? (2) How do these "tools" evolve? (3) How can we modulate or "turn off" these interfaces? (4) Can we mimic these "tools" in order to interface with cellular networks?  

A proof of concept of this methodology can be found in Einav and Gerber et al., 2008. In this paper, we used the same microfluidic platform to characterize a new function for a membrane protein from Hepatitis C virus, as well as find inhibitors to this new function. In less than 2 years, we now already have a compound that successfully passed preliminary clinical trials.